Cargando…
Integrated analysis identifies RAC3 as an immune‐related prognostic biomarker associated with chemotherapy sensitivity in endometrial cancer
Endometrial cancer (EC) is one of the most common gynaecological malignant tumours with a high incidence, leading to urgent demands for exploring novel carcinogenic mechanisms and developing rational therapeutic strategies. The rac family of small GTPase 3 (RAC3) functions as an oncogene in various...
Autores principales: | Huang, Pu, Qian, Yiyu, Xia, Yu, Wang, Siyuan, Xu, Cheng, Zhu, Xueqiong, Gao, Qinglei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424291/ https://www.ncbi.nlm.nih.gov/pubmed/37386813 http://dx.doi.org/10.1111/jcmm.17824 |
Ejemplares similares
-
Suppression of GCH1 Sensitizes Ovarian Cancer and Breast Cancer to PARP Inhibitor
por: Wang, Siyuan, et al.
Publicado: (2023) -
Bioinformatic profiling identifies prognosis-related genes in the immune microenvironment of endometrial carcinoma
por: Cheng, Pu, et al.
Publicado: (2021) -
BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity
por: Liu, Junxiu, et al.
Publicado: (2022) -
Integrated Bioinformatics Analysis of Serine Racemase as an Independent Prognostic Biomarker in Endometrial Cancer
por: Cui, Zhiwei, et al.
Publicado: (2022) -
A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2022)